Exencial Wealth Advisors LLC Grows Holdings in Danaher Corporation $DHR

Exencial Wealth Advisors LLC increased its position in Danaher Corporation (NYSE:DHR) by 56.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,595 shares of the conglomerate’s stock after acquiring an additional 6,681 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in Danaher were worth $3,673,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC boosted its stake in Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the period. Red Tortoise LLC boosted its stake in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Smallwood Wealth Investment Management LLC bought a new position in Danaher in the 1st quarter worth approximately $31,000. Finally, Ramirez Asset Management Inc. bought a new position in Danaher in the 2nd quarter worth approximately $40,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Rothschild & Co Redburn restated a “neutral” rating and issued a $220.00 price target (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft upped their price target on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Wednesday. Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday. TD Cowen increased their target price on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Seventeen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Stock Performance

NYSE:DHR opened at $218.06 on Thursday. The stock’s fifty day moving average is $202.24 and its 200 day moving average is $197.73. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $260.88. The firm has a market capitalization of $156.14 billion, a PE ratio of 44.96, a PEG ratio of 3.20 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.93% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the firm posted $1.71 EPS. Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is presently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.